SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing a surge in attention as its founder highlights revolutionary cancer treatment breakthroughs and AI-driven therapeutics on major news outlets, fueling intense community discussion about the company's "longevity" potential and pressuring short positions ahead of upcoming financial updates.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing a significant surge driven by strong Q4 results and upbeat guidance, fueled by accelerating demand for its 400G and 800G transceivers from hyperscale data centers in the booming AI sector. While many anticipate substantial future growth and a potential short squeeze, the community is also actively debating its current valuation and the implications of a recent $250 million stock offering.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending sharply higher amid intensifying geopolitical tensions in the Middle East, with the community actively discussing potential military action in Iran and rising crude oil prices, recalling the stock's historical volatility during past conflicts.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Space and Airborne Systems, Integrated Mission Systems, Communication Systems, and Aerojet Rocketdyne. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne and cyber domains. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land and sea domains. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

L3Harris Technologies is trending due to a significant Department of War investment in its Missile Solutions business ahead of a planned 2026 IPO, coupled with major contract wins in missile tracking and defense aircraft, while community discussions balance excitement over strategic partnerships and analyst upgrades against recent price volatility.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF ($VTI) is generating significant discussion as a bellwether for the U.S. market, with investors observing strong inflows and its proximity to all-time highs. The community is weighing these positive signals against prevailing political and economic uncertainties, prompting ongoing debate about diversification and market direction.

Green Satoshi Token

Green Satoshi Token (GSTSOL) is trending amidst a notable increase in volume and a perceived breakout, igniting strong community bullishness as many anticipate a significant "alt season" pump for the low-cap crypto despite historical frustrations.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is trending as investors intensely debate the potential approval of its dry eye drug Reproxalap ahead of a March 16 PDUFA date. Community sentiment is sharply divided, with optimists highlighting prior positive FDA interactions and the drug's clinical profile, while skeptics point to a recent PDUFA extension to review a field trial, past rejections, and cash runway concerns, suggesting a third Complete Response Letter is possible.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTX is a focus of conversation following strong Q4 earnings, a record backlog, and substantial new defense contracts for missile systems and aerospace components. The community is actively discussing the stock's potential upside due to escalating global geopolitical tensions and increased defense spending, reflected in aggressive call buying and analyst target raises.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is trending as it actively bids to merge its NBCUniversal division and theme parks with Warner Bros. Discovery, a move seen by the community as a potential game-changer for its streaming and content scale, while also preparing for the upcoming spin-off of its cable networks into Versant Media Group.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending after its Q4 earnings beat and strong cash flow were overshadowed by widespread investor frustration with CEO Peter Greenleaf's perceived lack of transparency. Community discussions are heavily focused on the ongoing delays and secrecy surrounding the AUR200 pipeline indications, intensifying speculation of a potential acquisition for the undervalued biotech.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Curaleaf Holdings, Inc. (CURLF) Reports Q4 Loss, Tops Revenue Estimates

Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +35.48% and +1.33%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Quanterix to Participate in Upcoming Investor Conferences

Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its executive leadership team will...

Envestnet Asset Management Inc. Grows Holdings in Quanterix Corporation $QTRX

Envestnet Asset Management Inc. boosted its position in Quanterix Corporation (NASDAQ:QTRX - Free Report) by 122.7% during the third quarter, according to its most recent 13F filing with the...

Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026

Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on...

Quanterix (NASDAQ:QTRX) Shares Up 0.7% - Time to Buy?

Quanterix (NASDAQ:QTRX) Trading Up 0.7% - Should You Buy...

Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test

QTRX submits a 510(k) to the FDA for its multi-analyte blood test aimed at evaluating cognitive symptoms for possible Alzheimer's disease.

Quanterix Submits FDA 510(k) For Multi-Analyte Blood Test For Alzheimer's Disease

(RTTNews) - Quanterix Corporation (QTRX) on Tuesday said it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for a multi-analyte algorithmic blood test to...

Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimers Disease Detection

Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced it has submitted a 510(k) premarket...

Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimers Risk Profiling

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced publication of a landmark study in the...

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on...

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Quanterix Corp

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Current Price	$6.55
Prev Close	$6.72
Open	$6.57
Dividend Yield	0.00%
50-Day Moving Average	$6.57
Beta	1.72
Avg. Volume	776,072.25
PE Ratio	-2.88

52-Week High	$8.77
52-Week Low	$4.05
Market Capitalization	$313.9M
EPS (Annual)	-$1.00
Price to Book	1.00
Revenue Per Employee	$291,764.33

QTRX
Quanterix Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest QTRX News

QTRXQuanterix Corp